Key Trends and Insights into the Preimplantation Genetic Testing Market: Growth Rate and Opportunities to 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How Does the Projected Growth of the Preimplantation Genetic Testing Market Compare Over the Forecast Period?
In recent times, there has been a swift expansion in the market size of preimplantation genetic testing. The market is projected to rise from a value of $0.83 billion in 2024 to $0.92 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.6%. The remarkable growth in the historical period is due to factors like the rising occurrence of genetic disorders, increased understanding of genetic testing, a surge in options for prenatal testing, the escalating demand for personalized medication, and a heightened emphasis on preventive healthcare.
The market size of preimplantation genetic testing is projected to witness a swift expansion in the coming years, escalating to a value of $1.41 billion in 2029, with a compound annual growth rate (CAGR) of 11.2%. This surge in the predicted period can be linked to the increasing count of fertility clinics, expansion in genetic counseling services, higher frequency of mature maternal age, better accessibility of cutting-edge genetic testing frameworks, and broadening application of PGT. Key trends, during this future period, will comprise the adoption of advanced sequencing technologies, the execution of broadened genetic panels, the creation of non-intrusive testing methods, innovations in embryo culture systems, and progress in genetic modification technologies.
Which Drivers Are Expected to Have the Greatest Impact on the Preimplantation Genetic Testing Market’s Growth?
The surge in in vitro fertilization (IVF) procedures is anticipated to fuel the expansion of the preimplantation genetic testing market in the future. These IVF procedures involve externally fertilizing an egg with sperm to create an embryo, which is then implanted into the uterus. The rise in IVF procedures can be attributed to advancements in reproductive technology, escalating rates of infertility, and increased public consciousness. This surge in IVF procedures is pushing the preimplantation genetic testing market upward by heightening the need for genetic examination of the embryos before transplantation. For instance, the Society for Assisted Reproductive Technology, a US-based organization, reported in April 2024 that 91,771 babies were conceived through in vitro fertilization (IVF) in 2022. Hence, the surge in in vitro fertilization (IVF) procedures is propelling the preimplantation genetic testing market.
Get Your Free Sample of the Global Preimplantation Genetic Testing Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=20596&type=smp
Who Are the Key Players Steering the Development of the Preimplantation Genetic Testing Market?
Major companies operating in the preimplantation genetic testing market are:
• Thermo Fisher Scientific
• Abbott Laboratories
• Laboratory Corporation of America Holdings
• Agilent Technologies Inc.
• Illumina Inc.
How Are Consumer Trends Shaping the Current and Future Landscape of the Preimplantation Genetic Testing Market?
Leading enterprises in the preimplantation genetic testing market are focusing on the creation of advanced next-generation sequencing (NGS) technologies to improve precision, efficiency, and pace in genetic screenings. This will allow a more detailed examination and more sound decisions for potential parents. The NGS technologies fast-track genetic study with instantaneous, high-efficiency examination of DNA and RNA. They provide significant insights into gene variations and gene expression, boosting precision and paving the way for bespoke medicine. For example, Thermo Fisher Scientific, a biotechnology firm based in the United States, introduced the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit in July 2023. These advanced next-generation sequencing tools are intended to improve IVF and ICSI research. These tools expedite workflows from sample preparation to the analysis of aneuploidy using state-of-the-art technology on the Ion torrent genexus integrated sequencer. This marks considerable progress in the preimplantation genetic testing market by enhancing embryo screening and raising success rates in assisted reproductive technology.
Pre-order Your Report for Quick and Easy Delivery!
Which Primary Segments of the Preimplantation Genetic Testing Market Are Driving Growth and Industry Transformations?
The preimplantation genetic testing market covered in this report is segmented –
1) By Procedure: Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis
2) By Product: Reagents And Consumables, Instruments, Software
3) By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In Situ Hybridization (FISH), Other Technologies
4) By Application: Chromosomal Abnormalities, Aneuploidy Screening, X-Linked Diseases, Embryo Testing, Human Leukocyte Antigen (HLA) Typing, Other Applications
5) By End User: Hospitals, Fertility Centers, Diagnostic Centers, Research Centers And Academic Labs
Subsegments:
1) By Preimplantation Genetic Screening (PGS): Array Comparative Genomic Hybridization (aCGH), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
2) By Preimplantation Genetic Diagnosis (PGD): Monogenic Disorders Testing, Chromosomal Abnormalities Testing, HLA Typing for Stem Cell Transplantation
Which Geographical Regions Are Shaping the Preimplantation Genetic Testing Market Growth?
North America was the largest region in the preimplantation genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preimplantation genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Defining Aspects of the Preimplantation Genetic Testing Market Landscape?
Preimplantation genetic testing (PGT) is a procedure that examines embryos for genetic issues before they are implanted during in vitro fertilization (IVF). It helps identify genetic abnormalities to avoid certain inherited conditions, improving the odds of a successful pregnancy. PGT enhances the likelihood of successful implantation, lowers the risk of miscarriage, and prevents genetic diseases.
Browse Through More Similar Reports By The Business Research Company:
Direct-To-Consumer (Dtc) Genetic Testing Global Market Report 2025
Genetically Modified Fruits Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genetically-modified-fruits-global-market-report
Optogenetics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
